Chenguang Biotech Group Cash Flow Reinvestment Rate

Latest as of September 2025: 0.07x

Chenguang Biotech Group cash flow reinvestment rate. Chenguang Biotech Group (300138) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥37.63 Million (capex CN¥37.63 Million ) from operating cash flow of CN¥524.96 Million. Explore debt repayment capacity of Chenguang Biotech Group to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.07x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥37.63 Million
Capex + Investments

Operating Cash Flow

CN¥524.96 Million
CNY

Capital Expenditures

CN¥37.63 Million
CNY

Cash Flow Reinvestment Rate of Chenguang Biotech Group (2008–2025)

Cash flow reinvestment rate of Chenguang Biotech Group from 2008 to 2025. Historical reinvestment intensity for Chenguang Biotech Group across 8 annual periods. Explore how much does Chenguang Biotech Group reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Chenguang Biotech Group Cash Flow Reinvestment Rate by Year (2008–2025)

Chenguang Biotech Group cash flow reinvestment rate by year from 2008 to 2025. Year-by-year capital reinvestment analysis for Chenguang Biotech Group. For the full cash flow conversion analysis, see 300138 cash flow metrics.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 1.21x CN¥257.81 Million CN¥212.91 Million CN¥135.26 Million ▲ +24.1%
2022 0.98x CN¥716.94 Million CN¥734.81 Million CN¥176.03 Million ▼ -92.4%
2021 12.86x CN¥821.73 Million CN¥63.90 Million CN¥280.82 Million ▲ +1423.3%
2020 0.84x CN¥446.93 Million CN¥529.41 Million CN¥436.88 Million ▲ +529.2%
2014 0.13x CN¥36.62 Million CN¥272.96 Million CN¥36.62 Million ▼ -93.9%
2011 2.21x CN¥181.72 Million CN¥82.18 Million CN¥181.72 Million ▼ -10.0%
2009 2.46x CN¥66.90 Million CN¥27.23 Million CN¥66.90 Million ▼ -14.5%
2008 2.87x CN¥26.05 Million CN¥9.06 Million CN¥26.05 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow